Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The effect of 8 mos of twice-weekly low- or higher intensity whole body vibration on risk factors for postmenopausal hip fracture.

Beck BR, Norling TL.

Am J Phys Med Rehabil. 2010 Dec;89(12):997-1009. doi: 10.1097/PHM.0b013e3181f71063.

PMID:
21403595
2.

Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study.

Verschueren SM, Roelants M, Delecluse C, Swinnen S, Vanderschueren D, Boonen S.

J Bone Miner Res. 2004 Mar;19(3):352-9. Epub 2003 Dec 22.

3.

[Effect of whole body vibration exercise on osteoporotic risk factors].

von Stengel S, Kemmler W, Mayer S, Engelke K, Klarner A, Kalender WA.

Dtsch Med Wochenschr. 2009 Jul;134(30):1511-6. doi: 10.1055/s-0029-1233971. Epub 2009 Jul 14. German.

PMID:
19603365
4.

Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.

Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G; EPIDOS Study Group.

Osteoporos Int. 2002 Jul;13(7):593-9.

PMID:
12111021
5.

[Whole body vibration (acceleration) training increases bone mineral density and serum levels of osteocalcin in elderly women].

Kotel'nikov GP, Piatin VF, Bulgakova SV, Shirolapov IV.

Adv Gerontol. 2010;23(2):257-62. Russian.

PMID:
21033380
6.

Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures.

Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MC, Bowman PJ, Ensrud KE.

J Am Geriatr Soc. 2004 Sep;52(9):1479-86.

PMID:
15341549
8.

Is tubal ligation a risk factor for low bone density and increased risk of fracture?

Fox KM, Cummings SR.

Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):101-5.

PMID:
7847513
9.

Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study.

Crabtree NJ, Kroger H, Martin A, Pols HA, Lorenc R, Nijs J, Stepan JJ, Falch JA, Miazgowski T, Grazio S, Raptou P, Adams J, Collings A, Khaw KT, Rushton N, Lunt M, Dixon AK, Reeve J.

Osteoporos Int. 2002 Jan;13(1):48-54.

PMID:
11883408
10.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171
11.

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY; Hip Intervention Program Study Group.

N Engl J Med. 2001 Feb 1;344(5):333-40.

12.

Height loss and osteoporosis of the hip.

Kantor SM, Ossa KS, Hoshaw-Woodard SL, Lemeshow S.

J Clin Densitom. 2004 Spring;7(1):65-70.

PMID:
14742889
13.

Relationship of body mass index with main limb fragility fractures in postmenopausal women.

Gnudi S, Sitta E, Lisi L.

J Bone Miner Metab. 2009;27(4):479-84. doi: 10.1007/s00774-009-0056-8. Epub 2009 Mar 10.

PMID:
19277453
14.

Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.

[No authors listed]

Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.

PMID:
20061894
15.

Prediction and discrimination of osteoporotic hip fracture in postmenopausal women.

Durosier C, Hans D, Krieg MA, Schott AM.

J Clin Densitom. 2006 Oct-Dec;9(4):475-95. Epub 2006 Aug 9. Review.

PMID:
17097535
16.

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women.

Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE.

Osteoporos Int. 2005 May;16(5):468-74. Epub 2004 Sep 21. Review.

PMID:
15448985
17.

Weighted vest exercise improves indices of fall risk in older women.

Shaw JM, Snow CM.

J Gerontol A Biol Sci Med Sci. 1998 Jan;53(1):M53-8.

PMID:
9467434
18.

[Osteoporosis--current diagnostics and therapy].

Pfeilschifter J.

Med Klin (Munich). 2009 Aug;104(8):632-41; quiz 642-3. doi: 10.1007/s00063-009-1135-2. German.

PMID:
19701734
19.

Predicting a second hip fracture.

Stewart A, Walker LG, Porter RW, Reid DM, Primrose WR.

J Clin Densitom. 1999 Winter;2(4):363-70.

PMID:
10677789
20.

Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women.

Leslie WD, Metge C, Ward L.

Osteoporos Int. 2003 Jun;14(4):334-8. Epub 2003 Apr 25.

PMID:
12730741
Items per page

Supplemental Content

Write to the Help Desk